Asides
FDA Backs Off New Drug Approvals
If you're new here, you may want to subscribe to the Natural Health RSS feed. Thanks for visiting!
After years of non-stop new drug approvals and a few high profile mistakes, such as Vioxx, it seems the FDA is finally slowing down and perhaps considering the safety of the consumer over the tremendous potential profits in the pharmaceutical industry. New drug applications were down 33% in 2006, which also had a clear impact on the number of overall approvals.
According to the
WSJ Health Blog, “The drug industry has fanned public mistrust by allegedly manipulating clinical data, concealing dangerous side effects and going gangbusters with marketing.” and public mistrust has finally forced the pendulum in the direction of safety rather than profits. Read the full story at
The WSJ Health Blog (image source).
Tags for this post

Tags:
approval drug fda,
approval fda process,
big pharma,
dangerous side effects,
drugs fda,
fda,
fda approval,
fda approvals,
fda approved drugs,
fda guidelines,
fda news,
fda registration,
new drug approvals,
pharmaceutical industry,
public mistrust,
vioxx
The information we present is not intended to replace a relationship with a qualified health care professional and is not intended to diagnose, treat, cure, or prevent disease. It is intended as a sharing of knowledge and information. You should not use this information to diagnose or treat any health problems,disease, or illness without consulting with your own physician or qualified medical professional.
Discussion
No comments for “FDA Backs Off New Drug Approvals”
Post a comment